Literature DB >> 26102023

Oxidative stress and lipid peroxidation are upstream of amyloid pathology.

Muriel Arimon1, Shuko Takeda1, Kathryn L Post1, Sarah Svirsky1, Bradley T Hyman1, Oksana Berezovska2.   

Abstract

Oxidative stress is a common feature of the aging process and of many neurodegenerative disorders, including Alzheimer's disease. Understanding the direct causative relationship between oxidative stress and amyloid pathology, and determining the underlying molecular mechanisms is crucial for the development of more effective therapeutics for the disease. By employing microdialysis technique, we report local increase in the amyloid-β42 levels and elevated amyloid-β42/40 ratio in the interstitial fluid within 6h of direct infusion of oxidizing agents into the hippocampus of living and awake wild type mice. The increase in the amyloid-β42/40 ratio correlated with the pathogenic conformational change of the amyloid precursor protein-cleaving enzyme, presenilin1/γ-secretase. Furthermore, we found that the product of lipid peroxidation 4-hydroxynonenal, binds to both nicastrin and BACE, differentially affecting γ- and β-secretase activity, respectively. The present study demonstrates a direct cause-and-effect correlation between oxidative stress and altered amyloid-β production, and provides a molecular mechanism by which naturally occurring product of lipid peroxidation may trigger generation of toxic amyloid-β42 species.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  4-Hydroxynonenal; Alzheimer's disease; Amyloid beta; Lipid peroxidation; Microdialysis; Oxidative stress; Presenilin; γ-Secretase

Mesh:

Substances:

Year:  2015        PMID: 26102023      PMCID: PMC4684986          DOI: 10.1016/j.nbd.2015.06.013

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  59 in total

1.  Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid.

Authors:  M A Lovell; W R Markesbery
Journal:  Arch Neurol       Date:  2001-03

2.  Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.

Authors:  Tanea T Reed; William M Pierce; William R Markesbery; D Allan Butterfield
Journal:  Brain Res       Date:  2009-04-15       Impact factor: 3.252

3.  4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.

Authors:  L M Sayre; D A Zelasko; P L Harris; G Perry; R G Salomon; M A Smith
Journal:  J Neurochem       Date:  1997-05       Impact factor: 5.372

Review 4.  The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism.

Authors:  Jie Shen; Raymond J Kelleher
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-29       Impact factor: 11.205

5.  Familial Alzheimer's disease presenilin 1 mutations cause alterations in the conformation of presenilin and interactions with amyloid precursor protein.

Authors:  Oksana Berezovska; Alberto Lleo; Lauren D Herl; Matthew P Frosch; Edward A Stern; Brian J Bacskai; Bradley T Hyman
Journal:  J Neurosci       Date:  2005-03-16       Impact factor: 6.167

6.  Regulation of tyrosinase trafficking and processing by presenilins: partial loss of function by familial Alzheimer's disease mutation.

Authors:  Runsheng Wang; Phuong Tang; Pei Wang; Raymond E Boissy; Hui Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-29       Impact factor: 11.205

7.  Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model.

Authors:  Monica Garcia-Alloza; Sarah A Dodwell; Melanie Meyer-Luehmann; Bradley T Hyman; Brian J Bacskai
Journal:  J Neuropathol Exp Neurol       Date:  2006-11       Impact factor: 3.685

8.  Novel cytochrome p450 bioactivation of a terminal phenyl acetylene group: formation of a one-carbon loss benzaldehyde and other oxidative products in the presence of N-acetyl cysteine or glutathione.

Authors:  Raju Subramanian; Janet Tam; Divesh Aidasani; Darren L Reid; Gary L Skiles
Journal:  Chem Res Toxicol       Date:  2011-03-11       Impact factor: 3.739

9.  Oxidative stress increases expression and activity of BACE in NT2 neurons.

Authors:  Elena Tamagno; Paola Bardini; Alessandra Obbili; Antonella Vitali; Roberta Borghi; Damiano Zaccheo; Maria A Pronzato; Oliviero Danni; Mark A Smith; George Perry; Massimo Tabaton
Journal:  Neurobiol Dis       Date:  2002-08       Impact factor: 5.996

10.  In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life.

Authors:  John R Cirrito; Patrick C May; Mark A O'Dell; Jennie W Taylor; Maia Parsadanian; Jeffrey W Cramer; James E Audia; Jeffrey S Nissen; Kelly R Bales; Steven M Paul; Ronald B DeMattos; David M Holtzman
Journal:  J Neurosci       Date:  2003-10-01       Impact factor: 6.167

View more
  36 in total

Review 1.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

Review 2.  Dynamic Nature of presenilin1/γ-Secretase: Implication for Alzheimer's Disease Pathogenesis.

Authors:  Katarzyna Marta Zoltowska; Oksana Berezovska
Journal:  Mol Neurobiol       Date:  2017-03-22       Impact factor: 5.590

3.  Intraneuronal Amylin Deposition, Peroxidative Membrane Injury and Increased IL-1β Synthesis in Brains of Alzheimer's Disease Patients with Type-2 Diabetes and in Diabetic HIP Rats.

Authors:  Nirmal Verma; Han Ly; Miao Liu; Jing Chen; Haining Zhu; Martin Chow; Louis B Hersh; Florin Despa
Journal:  J Alzheimers Dis       Date:  2016-05-05       Impact factor: 4.472

Review 4.  Neurodegeneration by oxidative stress: a review on prospective use of small molecules for neuroprotection.

Authors:  Ekta Singh; Giles Devasahayam
Journal:  Mol Biol Rep       Date:  2020-03-11       Impact factor: 2.316

5.  Antioxidant and Membrane Binding Properties of Serotonin Protect Lipids from Oxidation.

Authors:  Slim Azouzi; Hubert Santuz; Sandrine Morandat; Catia Pereira; Francine Côté; Olivier Hermine; Karim El Kirat; Yves Colin; Caroline Le Van Kim; Catherine Etchebest; Pascal Amireault
Journal:  Biophys J       Date:  2017-05-09       Impact factor: 4.033

6.  In vivo imaging of prodromal hippocampus CA1 subfield oxidative stress in models of Alzheimer disease and Angelman syndrome.

Authors:  Bruce A Berkowitz; Jacob Lenning; Nikita Khetarpal; Catherine Tran; Johnny Y Wu; Ali M Berri; Kristin Dernay; E Mark Haacke; Fatema Shafie-Khorassani; Robert H Podolsky; John C Gant; Shaniya Maimaiti; Olivier Thibault; Geoffrey G Murphy; Brian M Bennett; Robin Roberts
Journal:  FASEB J       Date:  2017-06-07       Impact factor: 5.191

Review 7.  Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria.

Authors:  Prashanth Gowda; P Hemachandra Reddy; Subodh Kumar
Journal:  Ageing Res Rev       Date:  2021-11-20       Impact factor: 10.895

8.  Centella asiatica Alleviates AlCl3-induced Cognitive Impairment, Oxidative Stress, and Neurodegeneration by Modulating Cholinergic Activity and Oxidative Burden in Rat Brain.

Authors:  Zeba Firdaus; Devendra Kumar; Sushil Kumar Singh; Tryambak Deo Singh
Journal:  Biol Trace Elem Res       Date:  2022-01-04       Impact factor: 4.081

9.  Tempol and perindopril protect against lipopolysaccharide-induced cognition impairment and amyloidogenesis by modulating brain-derived neurotropic factor, neuroinflammation and oxido-nitrosative stress.

Authors:  Mohammed Ragab Abdel-Aziz Ali; Amira Morad Hussein Abo-Youssef; Basim Anwar Shehata Messiha; Mahmoud Mohamed Khattab
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-03-30       Impact factor: 3.000

10.  The mitochondria-targeted antioxidant MitoQ inhibits memory loss, neuropathology, and extends lifespan in aged 3xTg-AD mice.

Authors:  Melissa L Young; James L Franklin
Journal:  Mol Cell Neurosci       Date:  2019-09-12       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.